Suptavumab Biosimilar - Anti-F,Fusion glycoprotein F0 mAb - Research Grade, Human, Monoclonal
Artikelnummer:
PTG-PX-TA1429-100
| Artikelname: |
Suptavumab Biosimilar - Anti-F,Fusion glycoprotein F0 mAb - Research Grade, Human, Monoclonal |
| Artikelnummer: |
PTG-PX-TA1429-100 |
| Hersteller Artikelnummer: |
PX-TA1429-100 |
| Alternativnummer: |
PTG-PX-TA1429-100 |
| Hersteller: |
ProteoGenix |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Spezies Reaktivität: |
Virus |
| Alternative Synonym: |
Anti-Fusion glycoprotein F0, Anti-F, H1H3592P3, REGN 2222, SAR-438584, SAR438584, REGN2222,CAS: 1629615-23-1 |
| Klonalität: |
Monoclonal |
| UniProt: |
P03420 |
| Puffer: |
0.01M PBS, pH 7.4. |
| Expression System: |
Eukaryotic expression |
| Target-Kategorie: |
F/Fusion glycoprotein F0 |